Spontaneous Iliopsoas Haematoma in Section Patients Undergoing Haemodialysis- An Enigma: A Case Series

Spontaneous Iliopsoas Haematoma in Section Patients Undergoing Haemodialysis- An Enigma: A Case Series

Chronic Kidney Disease (CKD) progression is associated with an increased risk of bleeding due to various reasons, some of which are iatrogenic. Bleeding at unusual sites, such as the iliopsoas muscle, is difficult to suspect as awareness about this condition is sparse, and the literature about the r...

Full description

Bibliographic Details
Main Authors:	Prajwal Kishore, Prashant G Kedlaya, Anantharam Jairam, Renuka Satish, Shashank Dhareshwar
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2023-11-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	anticoagulation apixaban bleeding chronic kidney disease renal replacement therapy
Online Access:	https://www.jcdr.net/articles/PDF/18702/65860_CE[Ra1]_F(KR)_QC&Ref(KK_SS)_PF1(AG_SHU)_PFA_NC(KM)_PN(OM).pdf

Similar Items

A Review of the Incidence Diagnosis and Treatment of Spontaneous Hemorrhage in Patients Treated with Direct Oral Anticoagulants
by: Kulothungan Gunasekaran, et al.
Published: (2020-09-01)

Direct Oral Anticoagulants (DOACs) are Non-Inferior to Vitamin K Antagonists for Patients Undergoing Transcatheter Aortic Valve Replacement with Indications of Anticoagulation
by: Jia Wang, et al.
Published: (2022-10-01)

Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study
by: Matthew A. Wanat, et al.
Published: (2019-10-01)

Comparative Effectiveness of Apixaban and Rivaroxaban Lead-in Dosing in VTE Treatment: Observational Multicenter Real-World Study
by: Omar A. Alshaya, et al.
Published: (2022-12-01)

Management of oral anticoagulants prior to emergency surgery or with major bleeding: A survey of perioperative practices in North America: Communication from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis
by: Jerrold H. Levy, et al.
Published: (2020-05-01)

The influence of residual apixaban on bleeding complications during and after catheter ablation of atrial fibrillation
by: Yutaro Mukai, et al.
Published: (2017-10-01)

Massive iliopsoas haematoma during the course of COVID‐19 pneumonia
by: Hiroaki Nagano, et al.
Published: (2023-01-01)

Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Benjamin J. R. Buckley, et al.
Published: (2022-06-01)

Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms
by: Angela Saviano, et al.
Published: (2022-11-01)

Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life
by: Paolo Zappulla, et al.
Published: (2021-04-01)

Spinal Cord Compression Secondary to a Spontaneous Spinal Haematoma in a Patient Newly Treated with Rivaroxaban
by: Javier Guerrero-Niño, et al.
Published: (2021-05-01)

Could Spontaneous Retroperitoneal Haematoma Present with Scrotal Mass? Mini-review and a case report
by: SS Qader, et al.
Published: (2009-01-01)

Evidence Gaps in the Era of Non–Vitamin K Oral Anticoagulants
by: Konstantinos N. Aronis, et al.
Published: (2018-02-01)

Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis
by: Daniel Caldeira, et al.
Published: (2022-02-01)

Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants
by: Perka Carsten
Published: (2011-11-01)

Bilateral iliopsoas haematomas
by: Taro Shimizu, et al.
Published: (2012-01-01)

The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis
by: Qi Wang, et al.
Published: (2020-03-01)

Apixaban
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Are outpatient anticoagulation management services the wave of the future (again)?
by: Bethany Samuelson Bannow
Published: (2022-05-01)

Rectus sheath hematoma associated with apixaban
by: Kulothungan Gunasekaran, et al.
Published: (2017-08-01)

Clinical Outcomes of Very Elderly Patients With Atrial Fibrillation Receiving On‐label Doses of Apixaban: J‐ELD AF Registry Subanalysis
by: Masato Okada, et al.
Published: (2021-08-01)

Venous thrombo-embolism (VTE) prevention of patients undergoing total hip and knee replacement: budget impact analysis of apixaban in Italy
by: Lorenzo Giovanni Mantovani, et al.
Published: (2013-09-01)

Large spontaneous median sacral artery pseudoaneurysm masquerading as hip pain
by: Joseph Faraj, MBChB, MS, et al.
Published: (2020-06-01)

PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST
by: D. A. Sychev, et al.
Published: (2015-09-01)

Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation
by: M. A. Gabitova, et al.
Published: (2020-01-01)

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
by: Alexander Cohen, et al.
Published: (2021-01-01)

GASTROINTESTINAL BLEEDING WITH THE USE OF NEW ORAL ANTICOAGULANTS: EPIDEMIOLOGY, RISK FACTORS, TREATMENT, AND PREVENTION
by: E. V. Moroz, et al.
Published: (2018-01-01)

SAFETY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION: A TWO-YEAR COHORT STUDY
by: A. V. Zhilenko, et al.
Published: (2017-07-01)

Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results
by: Gualtiero Palareti, et al.
Published: (2022-03-01)

Thrombocytopenia: A possible side effect of apixaban
by: Farid Sadaka
Published: (2019-12-01)

Thromboprophylaxis with apixaban and the risk of pulmonary embolism in patients undergoing knee replacement surgery
by: Madan Raj Aryal, et al.
Published: (2015-09-01)

Spontaneous Breast Haematoma after Heparin Anticoagulation
by: Imran Yaseen Gani, et al.
Published: (2020-06-01)

Apixaban, a Novel Oral Anticoagulant, Use to Resolute Arterial Patency in Radial Artery Occlusion Due to Cardiac Catheterization; A Pilot Randomized Clinical Trial
by: Afshin Amirpour, et al.
Published: (2023-11-01)

HOW NEW APPROACHES TO THE TREATMENT OF PULMONARY EMBOLISM AFFECT THE OUTCOME OF THE DISEASE?
by: M. Y. Gilyarov, et al.
Published: (2017-12-01)

A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)
by: Tomas L. Lindahl, et al.
Published: (2017-07-01)

Impact of anemia on the clinical outcomes in elderly patients with atrial fibrillation receiving apixaban: J-ELD AF registry subanalysis
by: Nobuaki Tanaka, et al.
Published: (2022-06-01)

Apixaban: An oral anticoagulant having unique mechanism of action with better safety and efficacy profile
by: Z A Fazeel
Published: (2016-01-01)

A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)
by: Hyeongsoo Kim, et al.
Published: (2020-01-01)

Single low-dose of apixaban in patients with atrial fibrillation after transcatheter aortic valve implantation
by: Gabriela Veiga-Fernández, et al.
Published: (2020-08-01)

Intracranial Hemorrhage following Lumbar Puncture in a Patient on Apixaban
by: Priyanka Vijapura, et al.
Published: (2019-09-01)